According to our (Global Info Research) latest study, the global Neurosurgery Shunts market size was valued at US$ 423 million in 2025 and is forecast to a readjusted size of US$ 613 million by 2032 with a CAGR of 5.4% during review period.
In 2025, global Neurosurgery Shunt production reached approximately 350 k units, with an average global market price of around US$1,175 per unit. Neurosurgical shunt is a medical device used in neurosurgical hydrocephalus shunt surgery. The key treatment for hydrocephalus is a shunt. A shunt is a thin tube implanted in the brain to drain away the excess CSF to another part of the body (often the abdominal cavity, the space around the bowel) where it can be absorbed into the bloodstream.
The global neurosurgery shunts market features a highly concentrated competitive landscape, with a small number of leading international companies dominating through long-term technological accumulation and comprehensive clinical evidence systems. Key players include Medtronic, Integra LifeSciences, B. Braun Medical, and Sophysa, who consolidate their market positions through continuous product iteration and strategic mergers and acquisitions. Technological innovation focuses on core clinical pain points, with product upgrades centered on programmable pressure regulation, antimicrobial coatings, anti-siphon mechanisms, and biocompatible material applications, aiming to reduce the incidence of common postoperative complications such as infection, shunt obstruction, and over-drainage. Some companies have introduced intelligent shunt systems with remote monitoring capabilities, providing new solutions for postoperative patient management.
The regulatory environment profoundly impacts market development. The U.S. FDA's 510(k) and PMA approval pathways, along with the EU's MDR regulations, have raised market entry barriers, requiring manufacturers to provide more comprehensive clinical data and long-term safety evidence. China's National Medical Products Administration classifies neurosurgery shunts as Class III high-risk medical devices under strict supervision, while the National Healthcare Security Administration has included relevant products in centralized procurement programs for high-value consumables, accelerating market price restructuring and domestic substitution.
Market demand shows structural changes, with treatment demand for adult normal pressure hydrocephalus growing steadily alongside population aging, while pediatric congenital hydrocephalus maintains a stable demand base. Mature markets are more sensitive to cost-effectiveness due to healthcare payment pressures, while emerging markets release significant unmet clinical needs as medical infrastructure improves and insurance coverage expands. Future market growth will primarily come from product upgrades driven by technological innovation and demand expansion in emerging markets, while companies need to balance rising compliance costs and price pressures.
This report is a detailed and comprehensive analysis for global Neurosurgery Shunts market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Neurosurgery Shunts market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Neurosurgery Shunts market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Neurosurgery Shunts market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Neurosurgery Shunts market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurosurgery Shunts
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurosurgery Shunts market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, MIETHKE (B.BRAUN), Integra LifeSciences, SOPHYSA, Natus, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Neurosurgery Shunts market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fixed-pressure Valve
Adjustable-pressure Valve
Flow-Regulating Valve
Market segment by Shunt Pathway
V-P Shunt
L-P Shunt
V-A Shunt
Others
Market segment by End User
Hospital
Clinic
Others
Market segment by Application
Adults
Children
Major players covered
Medtronic
MIETHKE (B.BRAUN)
Integra LifeSciences
SOPHYSA
Natus
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurosurgery Shunts product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neurosurgery Shunts, with price, sales quantity, revenue, and global market share of Neurosurgery Shunts from 2021 to 2026.
Chapter 3, the Neurosurgery Shunts competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurosurgery Shunts breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Neurosurgery Shunts market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neurosurgery Shunts.
Chapter 14 and 15, to describe Neurosurgery Shunts sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Neurosurgery Shunts. Industry analysis & Market Report on Neurosurgery Shunts is a syndicated market report, published as Global Neurosurgery Shunts Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Neurosurgery Shunts market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.